FDA proposes new rules for heart defibrillators

March 22, 2013

(AP)—The Food and Drug Administration will require makers of heart-zapping defibrillators to submit more data on their safety and effectiveness following years of recalls of the emergency devices.

Defibrillators use electric shocks to jolt the heart back to normal after patients collapse from . Once used exclusively in emergency rooms, they are now found in schools, office buildings and other public places.

The devices have been plagued by design and manufacturing flaws for years. The says it has received 45,000 reports of problems with defibrillators between 2005 and 2012.

Currently the FDA approves defibrillators through a fast-track process reserved for devices similar to ones already on the market.

The FDA proposal, when finalized, will require manufacturers to submit more extensive testing documentation before new defibrillators can be marketed.

Explore further: Commonly used defibrillators raise risk of problems

1 shares

Related Stories

Commonly used defibrillators raise risk of problems

August 31, 2011
When it comes to defibrillators, simpler may be safer, even though more complex machines are used on a majority of patients.

Wearable defibrillator can prevent death in people with arrhythmias

November 13, 2011
A wearable defibrillator can prevent sudden death in people with dangerous heart arrhythmias, according to research presented at the American Heart Association's Scientific Sessions 2011.

Vienna to use public defibrillators to fight heart attacks

September 27, 2012
Vienna will introduce 60 public defibrillators around the city over the coming months, in a bid to save lives by promoting quicker first aid in the event of a heart attack, authorities said Thursday.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.